Y

Yidu Tech

Health · Xuhui District, China · Founded 2013 · IPO 2021

Yidu Tech Inc. (2158.HK) operates as a healthcare technology company in China, providing artificial intelligence (AI) and big data solutions to the medical industry. The company was established in 2014 by Gong Yingying, who brought extensive experience from the finance and investment sectors, having worked at institutions like Deutsche Bank and Credit Suisse First Boston. Her background in economics and investment provided a strategic foundation for identifying and scaling technology solutions within the complex healthcare ecosystem. The company's core offering is its proprietary "AI Medical Brain," YiduCore, an intelligent platform that processes and analyzes vast amounts of authorized medical data. YiduCore is designed to convert unstructured and fragmented data from hospital IT systems into standardized, research-grade datasets. This platform underpins the company's three main business segments: Big Data Platform and Solutions, Life Sciences Solutions, and Health Management Platform and Solutions. Revenue is generated through providing these data intelligence platforms, analytics-driven solutions, and related operational services on a subscription or project basis to a diverse client base. Yidu Tech serves a wide array of participants in the healthcare value chain, including hospitals, pharmaceutical and biotech companies, research institutions, and regulators. For hospitals, the platform assists in improving clinical decision-making and operational efficiency. For life sciences companies, it provides real-world evidence and data-driven insights to accelerate clinical trials and drug development, which represents a significant and growing revenue stream. A major milestone was its Initial Public Offering (IPO) on the Hong Kong Stock Exchange on January 15, 2021, which raised approximately HK$4.1 billion and attracted cornerstone investors such as Tencent and the Canada Pension Plan Investment Board. For the fiscal year 2024, the company reported total revenue of RMB 807.1 million and an improved gross profit margin of 42.1%. Keywords: healthcare AI, medical big data, YiduCore, real-world data, clinical decision support, life sciences solutions, pharmaceutical R&D, data intelligence platform, Gong Yingying, health management solutions, precision medicine, data standardization, clinical trial optimization, healthcare analytics, disease knowledge graph, AI medical brain, public health solutions, real-world evidence, China healthcare technology, HKEX:2158